Fanconi Anemia D2 Protein Confers Chemoresistance in Response to the Anticancer Agent, Irofulven
Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-06-0427
Full Text
Open PDFAbstract
Available in full text
Date
December 1, 2006
Authors
Publisher
American Association for Cancer Research (AACR)